Development Of H3b-6545, A First-In-Class Oral Selective Er Covalent Antagonist (Serca), For The Treatment Of Erawt And Eramut Breast Cancer
Manav Korpal,Craig Furman,Xiaoling Puyang,Zhaojie Zhang,Zhenhua Wu,Deepti Banka,Subhasree Das,Benoit Destenaves,Lei Gao,Erika Hamilton,Ming-Hong Hao,Sean Irwin,Stephen Johnston, Jaya J. Joshi,Dejan Juric,Amy Kim,Tuong-Vi Nguyen,Marc Pipas,Timothy Pluard,Victoria Rimkunas,Nathalie Rioux,Joanne Schindler,Peter Smith,Michael Thomas,John Wang,Judy S. Wang,Markus Warmuth,Huilan Yao,Shihua Yao,Lihua Yu,Frederic H. Vaillancourt,David M. Bolduc,Nicholas A. Larsen,Guozhu Zheng,Sudeep Prajapati,Tarek Sahmoud,Antonio Gualberto,Ping Zhu CANCER RESEARCH(2021)
AI 理解论文
溯源树
样例